- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| AQUAPORIN Aktie jetzt für 0€ handeln | |||||
| 14.11. | Aquaporin A/S: Aquaporin Q3 2024 Trading Statement | 460 | GlobeNewswire (Europe) | Company announcement
No. 19/2024
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Copenhagen, Denmark, November 14, 2024 - Aquaporin A/S (ticker:... ► Artikel lesen | |
| 11.11. | AQUAPORIN A/S: Aquaporin secures milestone contract in Central Asia | 1 | Cision News | ||
| 07.11. | AQUAPORIN A/S: Aquaporin and Brenntag expand partnership to China | 25 | Cision News | ||
| 06.11. | Danish firm Aquaporin aims to expand footprint in China through CIIE | 1 | China Daily | ||
| 04.11. | AQUAPORIN A/S: The Next Generation of Aquaporin Inside® | 2 | Cision News | ||
| 25.10. | AQUAPORIN A/S: Aquaporin signs new contract with the European Space Agency | 2 | Cision News | ||
| 08.10. | AQUAPORIN A/S: Aquaporin lowers financial guidance for 2024 | 3 | Cision News | ||
| 24.08. | Aquaporin partners with Brenntag for APAC region & Turkiye | 5 | fibre2fashion | ||
| 23.08. | Aquaporin A/S: Aquaporin enters strategic partnership with industry leader Brenntag | 600 | PR Newswire | Company announcementNo. 17/2024
Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694
KONGENS LYNGBY, Denmark, Aug. 23, 2024 /PRNewswire/... ► Artikel lesen | |
| 22.08. | Aquaporin A/S: Aquaporin announces results for first half 2024 with revenue increase of 44% | 184 | GlobeNewswire (Europe) | Company announcement
No. 16/2024
Aquaporin A/S
Nymøllevej 78
DK-2800 Kongens Lyngby
aquaporin.com
Company registration no.: DK28315694
Kongens Lyngby, Denmark, August 22, 2024 - Aquaporin A/S... ► Artikel lesen | |
| 14.08. | AQUAPORIN A/S: Aquaporin to host half-year 2024 results webcast on August 22 | 1 | Cision News | ||
| 16.07. | AQUAPORIN A/S: Aquaporin-powered purifier now available in Turkey | 2 | Cision News | ||
| 11.07. | AQUAPORIN A/S: Aquaporin secures order with large EMEA water treatment company | 5 | Cision News | ||
| 23.05. | Aquaporin A/S: Aquaporin Q1 2024 Trading Statement - maintains guidance with strong orderbook | 266 | GlobeNewswire (Europe) | Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694
Company announcement
No. 15/2024
Copenhagen, Denmark, May 23, 2024 - Aquaporin A/S (ticker:... ► Artikel lesen | |
| 29.04. | Nasdaq Copenhagen A/S: Aquaporin A/S -admittance to trading and official listing of new shares due to completion of rights issue | 274 | GlobeNewswire | The share capital of Aquaporin A/S has been increased. The admittance of
trading and official listing of new shares will take effect as per 30 April
2024 in the ISIN below.
ISIN: DK0061555109... ► Artikel lesen | |
| 25.04. | Aquaporin A/S: Aquaporin raises DKK 172 million | 360 | PR Newswire | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY... ► Artikel lesen | |
| 08.04. | XFRA CAPITAL ADJUSTMENT INFORMATION - 08.04.2024 | 840 | Xetra Newsboard | Das Instrument X2Y IT0005495871 YOLO GROUP S.P.A. O.N. EQUITY wird ex Kapitalmassnahme gehandelt am 08.04.2024 The instrument X2Y IT0005495871 YOLO GROUP S.P.A. O.N. EQUITY is traded ex capital adjustment... ► Artikel lesen | |
| 05.04. | Aquaporin A/S: Aquaporin publishes prospectus and initiates rights issue | 306 | PR Newswire | NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CHINA, HONG KONG, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR IN ANY... ► Artikel lesen | |
| 05.04. | Nasdaq Copenhagen A/S: Aquaporin A/S - rights issue, admission to trading and official listing of subscription rights | 369 | GlobeNewswire | Subscription rights in Aquaporin A/S will be admitted to trading and official
listing on Nasdaq Copenhagen as per 8 April 2024. As of the same date, ISIN
DK0061555109 (AQP) will be traded excl. of subscription... ► Artikel lesen | |
| 05.04. | Aquaporin A/S: Aquaporin announces full-year 2023 results, with year-on-year revenue growth of 95% | 388 | PR Newswire | Aquaporin A/S, Nymøllevej 78, DK-2800 Kongens Lyngby, aquaporin.com, Company registration no.: DK28315694Company announcementNo. 06/2024
COPENHAGEN, Denmark, April 5, 2024 /PRNewswire/... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ADMA BIOLOGICS | 17,400 | -2,68 % | ADMA Biologics, Inc.: ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility | ||
| QIAGEN | 42,900 | +0,04 % | Sartorius, Qiagen, Siemens Energy, DHL Group, Adidas, Puma: DAX-Ausblick | Nach seiner jüngsten Rekordjagd hat der DAX in der abgelaufenen Woche etwas Luft geholt. Unter dem Strich legte das größte deutsche Börsenbarometer trotzdem 21 Punkte zu und schloss mit knapp 20.406... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 76,52 | +5,05 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Announces Rare Pediatric Disease Designation Granted for Relutrigine in Dravet Syndrome | Dravet syndrome is a genetic developmental and epileptic encephalopathy (DEE) often caused by a mutation in SCN1A This is the third Rare Pediatric Disease Designation for relutrigine, adding to those... ► Artikel lesen | |
| ARCUTIS BIOTHERAPEUTICS | 14,990 | +6,24 % | Arcutis Biotherapeutics, Inc.: Arcutis Submits ZORYVE (roflumilast) Cream 0.05% Supplemental New Drug Application to the FDA for the Treatment of Children Aged 2 to 5 with Mild to Moderate Atopic Dermatitis | ZORYVE cream 0.05% provided meaningful disease clearance and rapid reduction in itch in pivotal trialsRoflumilast cream was well tolerated and demonstrated a favorable safety and tolerability profile... ► Artikel lesen | |
| EVOTEC | 8,405 | +1,08 % | CompuGroup, Evotec, Kion Group, Nagarro, ProSiebenSat.1 Media, TUI u.a. - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| VIR BIOTECHNOLOGY | 7,340 | -0,27 % | Vir Biotechnology Reports Third Quarter 2024 Financial Results and Provides Corporate Update | SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today provided a corporate update and reported financial results for the third quarter ended September 30, 2024.
"This quarter... ► Artikel lesen | |
| CELCUITY | 12,460 | +3,83 % | Celcuity Inc.: Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium | Median overall survival (OS) among patients with HR+, HER2- advanced breast cancer who were treatment-naïve in the advanced setting was 77.3 months Median OS among patients previously treated with... ► Artikel lesen | |
| CONTINEUM THERAPEUTICS | 13,500 | +1,12 % | Contineum Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights | SAN DIEGO--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (Nasdaq: CTNM), a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that... ► Artikel lesen | |
| BIONTECH | 108,60 | +0,09 % | Abstieg und Hoffnung: So steht es um den BioNTech-Konkurrenten Moderna | Die Aktie von Moderna hat in den vergangenen zwölf Monaten eine enttäuschende Entwicklung hingelegt. Im Nasdaq 100 gehört sie in diesem Zeitraum zu den zwei schlechtesten Werten. Nun muss sie den Index... ► Artikel lesen | |
| HUMACYTE | 4,635 | +33,77 % | Pre-market Movers: My Size, Nvni Group, Psyence Biomedical, Humacyte, PainReform | BRASILIA (dpa-AFX) - The following are some of the stocks making big moves in Friday's pre-market trading (as of 07.55 A.M. ET).In the Green My Size, Inc. (MYSZ) is up over 372% at $6.43.
Nvni... ► Artikel lesen | |
| AMGEN | 252,90 | +0,18 % | What's Going On With Amgen Stock On Friday? | ||
| JANUX THERAPEUTICS | 56,70 | -0,09 % | Pre-market Movers: Cheetah Net Supply Chain Service, NLS Pharmaceutics, PSQ Holdings, Janux Therapeutics, Coherus BioSciences | CANBERA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.45 A.M. ET).In the Green Cheetah Net Supply Chain Service Inc. (CTNT) is up... ► Artikel lesen | |
| FOGHORN THERAPEUTICS | 5,140 | +3,21 % | Foghorn Therapeutics, Inc.: Foghorn Therapeutics Provides Update on FHD-286 Clinical Development Program and Strategic Priorities | Objective clinical responses by standard response criteria observed in Phase 1 dose escalation trial for FHD-286 in combination with decitabine in patients with relapsed and/or refractory AML; efficacy... ► Artikel lesen | |
| IMMUNOVANT | 25,880 | +0,86 % | Immunovant (NASDAQ:IMVT) Trading Down 5.2% - Here's Why | ||
| RECURSION PHARMACEUTICALS | 6,035 | -0,90 % | Recursion Pharmaceuticals Reports Grant of Inducement Awards as Permitted by the Nasdaq Listing Rules | Salt Lake City, Utah, Dec. 20, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. ("Recursion") (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug... ► Artikel lesen |
Das Unternehmen AQUAPORIN A/S kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 2,270 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AQUAPORIN A/S finden Sie auf Wallstreet Online.
